AGTC News and Press, Applied Genetic Technologies Corporation From 05/05/21

Announcing its Q1 2021 results, Editas Medicine (EDIT) said that the cash and equivalents as of March 31 have improved to $6.5M indicating ~41.3% growth from the 2020-year end, and along with interest, the liquidity could fund its operations and capex until at least 2023.Howeve...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced...

-Company remains on track to present additional 12-month data from the XLRP and achromatopsia clinical trials in the second quarter of 2021- ALACHUA, Fla. and CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnolog...

Biotech Penny Stocks On Robinhood To Watch Right Now Penny stocks are in a bright spotlight heading into the month ahead. With Monday marking the first trading day of May, it’s important to take time, analyze trends and get ready for what the market has in store. But, whether you...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

SAN DIEGO, April 28, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the upcoming presentation of preclinical proof-of-concept data for OTO-825 at the American So...

Cassava a buy on strength of simufilam dataB. Riley has initiated shares of Cassava Sciences (SAVA) with a buy rating and a $78 price target.Given its most recent close, that represents upside of ~46%.Analyst Mayank Mamtani writes that the strength of the company Alzheimer's candidate simufil...

Gainers: [[HSII]] +8.8%. [[RRR]] +5.5%. [[MVIS]] +4.7%. [[WIRE]] +3.9%. [[ILPT]] +3.0%.Losers: [[VNET]] -8.9%. [[AGTC]] -8.3%. [[HYFM]] -8.3%. [[ATVI]] -6.8%. [[RNWK]] -5.3%. For further details see: HSII, RRR, VNET and AGTC among after-hours movers

Applied Genetic Technologies (AGTC) has lost ~4.9% in post-market trading after announcing the resignation of its chief scientific officer Mark Shearman.Shearman is leaving to ‘pursue another opportunity,’ and will remain with the company through June 4, 2021, to ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...